Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Cash-and-Equivalents" stands at 234.60 Billion Japanese Yens as of 06/30/2025.
As of the end of Kyowa Kirin Co Ltd's second quarter, the item "Cash and Equivalents" stands at 234.60 Billion JPY. This represents an increase of 9.44 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -24.60 percent compared to the value the year prior.
The 1 year change in percent is -24.60.
The 3 year change in percent is -30.98.
The 5 year change in percent is -3.66.
The 10 year change in percent is 1,339.99.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |